A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

Exclusion Criteria

• •1. Women who are pregnant or breastfeeding.
• •2. Women with a positive pregnancy test result on enrollment or prior to investigational product administration.
• •3. Subjects with a history of surgery that could affect gastrointestinal motility
• •4. Subjects with inflammatory bowel disease
• •5. Clinically significant chronic infection (eg. AIDS, etc), or significant medical or psychiatric illness.
• •6. Serious cardiovascular disease (including QT prolongation defined as QTc interval ≥ 450msec) or respiratory disease
• •7. History of alcohol or drug abuse within the previous one year.
• •8. Subjects with mental illness (e.g. schizophrenia, dementia etc) that may render the inability to complete the study
• •9. Physical and Laboratory Test Findings
• •10. Administration of any other investigational product or participation in other clinical trials within 3 months prior to randomization.